Peter Anthony Hall

Peter Anthony Hall's AcademicInfluence.com Rankings

Peter Anthony Hall

Biology

#10013

World Rank

#13291

Historical Rank

Cell Biology

#452

World Rank

#463

Historical Rank

Molecular Biology

#1415

World Rank

#1442

Historical Rank

biology Degrees

Download Badge

Biology

Peter Anthony Hall's Degrees

Bachelors Biology University of California, Berkeley
PhD Cell Biology University of California, San Francisco

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Peter Anthony Hall Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Anthony Hall's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms (1990) (1486)
The p53 pathway (1999) (1429)
Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. (1994) (868)
The p53 tumour suppressor gene (1998) (837)
High levels of p53 protein in UV-irradiated normal human skin. (1993) (692)
p53 In tumour pathology: Can we trust immunohistochemistry?—revisited! (1994) (625)
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. (1994) (621)
In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological states (1993) (595)
Stem cells: the generation and maintenance of cellular diversity. (1989) (520)
Review: assessment of cell proliferation in histological material. (1990) (465)
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. (1997) (376)
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. (1991) (335)
The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma (1988) (301)
The pathobiology of the septin gene family (2004) (298)
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction (1991) (295)
Ki-ras oncogene activation in preinvasive pancreatic cancer. (1992) (269)
The complexities of proliferating cell nuclear antigen (1992) (267)
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (1987) (259)
Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. (1995) (247)
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. (2000) (245)
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. (1995) (239)
The p53 response to ionising radiation in adult and developing murine tissues. (1996) (230)
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues (1990) (217)
Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. (2001) (216)
The prohibitin family of mitochondrial proteins regulate replicative lifespan (1997) (212)
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer (1991) (212)
The epidermal growth factor receptor in human pancreatic cancer (1992) (203)
Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations (1988) (200)
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. (1991) (189)
Expression profiling the human septin gene family (2005) (184)
Ki67—Structure, function, and new antibodies (1992) (184)
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo (2016) (170)
The c‐erbB‐2 proto‐oncogene in human pancreatic cancer (1990) (169)
Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas (1992) (166)
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA) (1991) (156)
The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigens (1993) (150)
Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reports (1989) (144)
Characterization of the expression pattern of p63α and δnp63α in benign and malignant oral epithelial lesions (2000) (139)
MDM2--arbiter of p53's destruction. (1997) (132)
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle (2000) (121)
Characterisation of the interaction between PCNA and Gadd45. (1995) (118)
Expression of the ‘DEAD box’ RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus (1998) (118)
APC EXPRESSION IN NORMAL HUMAN TISSUES (1997) (114)
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. (1994) (113)
Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. (1993) (111)
Characterization of integrin chains in normal and neoplastic human pancreas (1991) (110)
EDITORIAL. p53—INTEGRATING THE COMPLEXITY (1996) (110)
Tumour suppressors: A developing role for p53? (1997) (109)
Prognostic and predictive factors. (2004) (107)
Transcriptional activation of tyrosinase and TRP‐1 by p53 links UV irradiation to the protective tanning response (2000) (102)
HIV Treatment and Associated Mitochondrial Pathology (2014) (99)
The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors (2005) (99)
Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours (2005) (98)
Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. (1992) (97)
Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis (2006) (90)
Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long‐standing ulcerative colitis (1986) (90)
Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature (1986) (89)
Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. (1994) (85)
Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. (1993) (84)
Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma (1988) (84)
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis (1991) (83)
Do septins have a role in cancer? (2005) (82)
Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. (1996) (80)
Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds (1993) (79)
Paraffin section immunohistochemistry. I. Non‐Hodgkin's lymphoma (1988) (76)
Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. (1996) (75)
Ki67: from antibody to molecule to understanding? (1995) (72)
Expression of the p53 homologue p63α and ΔNp63α in normal and neoplasticcells (2000) (70)
p53 expression is common in malignant mesothelioma (1992) (70)
Assessing p53 in clinical contexts: unlearned lessons and new perspectives (2006) (69)
The role of the p53 protein in the apoptotic response. (1994) (69)
Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. (2000) (68)
Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. (1999) (66)
A functional model of adult human prostate epithelium. The role of androgens and stroma in architectural organisation and the maintenance of differentiated secretory function. (1992) (66)
A comparison of nucleolar organizer region staining and Ki‐67 immunostaining in non‐Hodgkin's lymphoma (1988) (64)
New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. (1987) (63)
Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. (1987) (63)
Translational control of SEPT9 isoforms is perturbed in disease. (2007) (62)
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer (1992) (58)
Assessment of cell proliferation in pathology—what next? (1995) (58)
The biochemical characterization of the DNA binding activity of pKi67 (2000) (55)
A Strategy for Defining Biologically Relevant Levels of p53 Protein Expression in Clinical Samples with Reference to Endometrial Neoplasia (2005) (55)
Assessing apoptosis: a critical survey. (1999) (54)
Malignant lymphoma in the gastrointestinal tract. (1991) (54)
SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity (2005) (54)
Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. (1987) (54)
Mammalian septins: dynamic heteromers with roles in cellular morphogenesis and compartmentalization (2012) (52)
The c-erb B-2 proto-oncogene in human pancreatic cancer. (1990) (47)
Does the p53 Up-Regulated Gadd45 Protein Have a Role in Excision Repair? (1995) (47)
Why is p53 protein stabilized in neoplasia? Some answers but many more questions! (1998) (46)
Assessment of Cell Proliferation in Clinical Practice (1992) (44)
p53--integrating the complexity. (1996) (42)
Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. (2002) (40)
Growth factors and oncogenes in pancreatic cancer. (1990) (40)
Fen1 expression: a novel marker for cell proliferation (1998) (39)
Properties of SEPT9 isoforms and the requirement for GTP binding (2004) (39)
Septin genomics: a road less travelled (2011) (39)
A nude mouse xenograft model of fetal intestine development and differentiation. (1992) (39)
Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. (1993) (38)
Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia. (1991) (38)
Models of pancreatic cancer. (1993) (36)
TUC: The Growth of a Pressure Group 1868-1976. (1981) (34)
Multicentric reticulohistiocytosis. Detailed immunophenotyping confirms macrophage origin. (1990) (34)
The p53 tumour suppressor gene and tumour prognosis: is there a relationship? (1995) (33)
Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells. (2000) (33)
Acetone/periodate‐lysine‐paraformaldehyde (PLP) fixation and improved morphology of cryostat sections for immunohistochemistry (1987) (32)
The clinical relevance of the p53 tumour suppressor gene * (1994) (32)
Cancer Growth and Progression (1990) (30)
The Immunocytochemical Detection of P53 Protein In Cytological Specimens: Technical Considerations (1994) (29)
Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. (1995) (29)
New perspectives on neoplasia and the RNA world (2005) (28)
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs (2005) (26)
Expression of the p53 homologue p63α and ΔNp63α in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein (2001) (25)
Quality really matters: the need to improve specimen quality in biomedical research (2012) (24)
Control of differentiation in a rectal adenocarcinoma cell line: The role of diffusable and cell‐associated factors (1991) (22)
Genetics of growth arrest and cell death: key determinants of tissue homeostasis. (1994) (21)
In situ demonstration of renal tubular regeneration using the monoclonal antibody Ki67. (1988) (21)
Langerhans cell histiocytosis: an unusual case illustrating the value of immunohistochemistry in diagnosis (1987) (20)
Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer (2013) (20)
The Trp53 Pathway Is Induced In Vivo by Low Doses of Gamma Radiation (2001) (19)
The fibroblast growth factor and receptor multigene families (1993) (19)
Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats. (2013) (19)
Comparison of manual data coding errors in two hospitals. (1986) (19)
Immunohistochemistry detects mismatch repair gene defects in colorectal cancer (2006) (18)
An introduction to genes, genomes and disease (2010) (17)
Demonstration of lymphoid antigens in decalcified bone marrow trephines. (1987) (17)
Long noncoding RNA BHLHE40‐AS1 promotes early breast cancer progression through modulating IL‐6/STAT3 signaling (2020) (17)
Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology. (1993) (17)
Lymphoplasmacytoid lymphoma: An immunohistological study (1987) (16)
The Challenge of p53: Linking Biochemistry, Biology, and Patient Management (1998) (16)
Gadd45 mutations are uncommon in human tumour cell lines (2000) (16)
Epithelial–mesenchymal interactions can influence the phenotype of carcinoma metastases in the mucosa of the intestine (1990) (15)
Endocrine cells of the human gastrointestinal tract have no proliferative capacity (1995) (15)
Endocrine cells of the human gastrointestinal tract have no proliferative capacity (2004) (14)
Expression of the nuclear membrane protein statin in cycling cells (1993) (13)
Expression of p53 in reactive mesothelium (1993) (13)
Molecular differences between human and experimental pancreaticobiliary diversion-induced rat pancreatic neoplasia. (1991) (12)
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth‐regulated cross‐reacting species p170 (1998) (12)
The Kinetic Organisation of Tissues (1992) (11)
Carcinoma of the gall bladder metastatic to the cervix. Case report (1986) (9)
Immunohistochemistry in district general hospitals in England and Wales. (1987) (9)
Keratin expression in human tissues and neoplasms: other issues (2003) (9)
The gut-associated lymphoid tissue and its tumours. (1990) (8)
Do we really need a higher necropsy rate? (1999) (8)
Septins and Human Disease (2008) (7)
DNA ploidy analysis in histopathology. DNA ploidy studies in pathology-a critical appraisal. (2004) (7)
An inter-observer and intra-observer variability study on the diagnosis of lymph node biopsy specimens. (1992) (6)
Caecal lipomas mimicking colonic angiodysplasia. (1985) (6)
Getting Your Paper Published: An Editor’s Perspective (2011) (6)
How does The Journal of Pathology deal with conflict of interest? (2009) (5)
Immunohistochemistry of Hodgkin's disease (1989) (5)
Ki 67 : from antibody to molecule to understanding ? logic characterisation of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki 67 (5)
The Journal of Pathology's approach to publication ethics and misconduct (2011) (5)
Expression of p21waf1/cip1, mdm2 and p53 in vivo: analysis of cytological preparations (1996) (5)
Histiocytosis X mimicking recurrent malignant disease: a report of two cases. (1988) (4)
Introduction to the Cellular and Molecular Biology of Cancer. 3rd edn. L. M. Franks and N. M. Teich. Oxford University Press, Oxford, 1997. No. of pages: 468. Price: £55.00 (Hardback). ISBN: 0 19 854854 0 (1998) (4)
Non-proliferative capacity of endocrine cells of the human gastro-intestinal tract (1996) (4)
Analysis of apoptosis in tissue sections. (2001) (4)
A monoclonal antibody (anti-L-35) which reacts with human osteoclasts and cells of the mononuclear phagocyte system. (1988) (4)
Analysis of apoptosis in tissue sections. (1999) (4)
Appendix B: Mammalian Septin Nomenclature (2008) (4)
Value of CD 1 5 immunostaining in diagnosing Hodgkin ' s disease : a review of published literature (3)
Distribution of the FGF-FGFR multigene family in normal and human atherosclerotic arteries. Evidence of a role for FGF-2 in plaque neovascularisation using an in vitro model of angiogenesis (1995) (3)
A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. (1988) (2)
Molecular and cellular themes in cancer research: II (2005) (2)
The Journal of Pathology: Clinical Research. A new step in the evolution of publishing in pathology* (2015) (1)
Cell proliferation (1991) (1)
Leader Ki 67 : from antibody to molecule to understanding ? (2003) (1)
Function of the p53 Gene Family (1999) (1)
Appendix C: Septin Meetings and Workshops (2008) (1)
Abstract 260: Elucidating the roles of the alternatively spliced transcripts of Septin 9 (2010) (1)
disease : correlation with morphology . nucleolar organiser regions in Hodgkin ' s Proliferating cell nuclear antigen ( PCNA ) and (1)
Abstract 5012: Regulation of splicing of SEPT9 in health and disease (2011) (0)
Do aggressive subclones within primary colorectal cancer give rise to liver metastases? (2005) (0)
Assessment of follicular lymphomas (1989) (0)
Proliferative and differentiative heterogeneity in epithelial cell populations (1993) (0)
An Introduction to the Septins (2008) (0)
Septins: 2008 and beyond (2008) (0)
An unusual paper about an important topic (2008) (0)
Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs (2012) (0)
Of spots, stripes and muddled thinking! (1993) (0)
Do aggressive subclones within primary colorectal cancer give rise to liver metastases? (2005) (0)
Cellular stresses Adaptive responses Apoptosis Growth arrest Other ? ? ? ? ? ? ? (1999) (0)
Expression of the p53 homologue p63 (cid:225) and (cid:196) Np63 (cid:225) in the neoplastic sequence of Barrett’s oesophagus: correlation with morphology and p53 protein (2001) (0)
More developments at The Journal of Pathology (2010) (0)
Regulation of endogenous septin scaffolds and the role of p53 and p63 (2012) (0)
139 Inhibition of osteolysis by CSF-1R antagonist in MM.1S orthotopic multiple myeloma model (2010) (0)
Septin 9 interacts with cytoskeletal factors leading to altered cell migration and resistance to microtubule-disrupting drugs. (2004) (0)
Differential diagnosis of metastatic undifferentiated carcinoma. (1989) (0)
Distinct Chromosomal Alterations Segregate with SEPT6 Expression Levels in Leukaemia (2012) (0)
Cellular stresses Adaptive responses Apoptosis Growth arrest Other ? ? ? ? ? ? ? (1999) (0)
antigen in gastric carcinoma . Prognostic value of proliferating cell nuclear (2004) (0)
Dr Hall and colleagues comment (1987) (0)
Letter to the editor (1993) (0)
Regulating and replacing suppressor gene function with small synthetic molecules; design of an active synthetic suppressor protein (1996) (0)
Angiolymphoid Hyperplasia with Eosinophilia (1987) (0)
Regulation of splicing of SEPT9 in health and disease (2011) (0)
The Clinical Journal of Pathology: A new step in the evolution of publishing in pathology (2014) (0)
Abstract 244: Effects of upregulation of Sept6 v4** splice variant in AML (2010) (0)
Abstract 3804: The pathobiology of perturbed SEPT9 expression in ovarian neoplasia (2011) (0)
Guest Lecture 9.00–9.45 Wednesday 17 September 2003 (2003) (0)
Diagnosis of Cytomegalovirus Infection by In Situ Hybridization (1989) (0)
Differential expression of SEPT9 splice variants in malignant ovarian tumors and during the cell cycle (2008) (0)
Proliferating cellnuclear antigen expression innon-cycling cells maybe induced bygrowth factors invivo (1994) (0)
The Journal of Pathology: Clinical Research : a new step in the evolution of publishing in pathology (2014) (0)
535 POSTER Characterization of a fully human PDGFRa antibody that reduces tumor growth and stromal infiltration in a xenograft model of non-small cell lung cancer (2008) (0)
Cell proliferation in pathology. (1993) (0)
Abstract 2252: Septin 6 in malignant melanoma (2010) (0)
Sept9_v4 Regulates Cdc42 activation and promotes directional protrusion (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Anthony Hall?

Peter Anthony Hall is affiliated with the following schools:

University of Dundee

Peter Anthony Hall's Academic­Influence.com Rankings

Peter Anthony Hall's Degrees

Similar Degrees You Can Earn

Why Is Peter Anthony Hall Influential?

Peter Anthony Hall's Published Works

Published Works

What Schools Are Affiliated With Peter Anthony Hall?

Peter Anthony Hall's AcademicInfluence.com Rankings